NDC11 13107028205
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 13107-0282-05 | 13107-0282 |
| 13107-0282-5 | 13107-0282 |
| 13107-282-05 | 13107-282 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | Aurolife Pharma LLC | 69451c35-dd9a-4690-8d5e-4dcfa8837620 | 2024-01-20 | Boxed warning, Warnings, Adverse reactions | 13107-282-05 13107-282 13107028205 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.